Earnings News

Quarterly earnings reports, revenue surprises, and EPS results from top companies. Follow earnings season with analyst estimates and post-earnings stock moves.

Cisco Gains Ahead of Earnings Amid Tech Sector Volatility
Earnings James Calloway

Cisco Gains Ahead of Earnings Amid Tech Sector Volatility

Cisco shares rose 3% to $84.82 Friday as investors positioned for quarterly results and key economic data next week. The company reports February 11 with analysts expecting $1.02 EPS on $15.12 billion revenue.

CSCO
Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings
Earnings James Calloway

Healthcare Sector Sees Divergence: Molina Plunges on Outlook, XLV Gains Amid Regulatory Warnings

Molina Healthcare plummeted 25.5% after slashing its 2026 profit forecast and announcing a Medicare Part D exit, while the Health Care Select Sector SPDR Fund (XLV) rose 1.8%. Regulatory warnings on compounded obesity drugs added pressure to the sector.

JNJ LLY PFE UNH
Amazon Shares Drop 5.6% on $200 Billion AI Spending Forecast
Earnings James Calloway

Amazon Shares Drop 5.6% on $200 Billion AI Spending Forecast

Amazon stock declined sharply after projecting a major increase in capital expenditures for 2026, even as broader markets reached new highs. Investors are scrutinizing the returns from massive tech investments in artificial intelligence.

AMZN NVDA MSFT GOOGL
Home Depot Shares Edge Higher Ahead of Key Economic Data, Q4 Earnings
Earnings James Calloway

Home Depot Shares Edge Higher Ahead of Key Economic Data, Q4 Earnings

Home Depot stock gained 0.7% Friday as investors await delayed jobs and inflation reports. The home improvement retailer's Q4 earnings, due Feb. 24, will test demand in a cautious housing market.

HD
AbbVie Shares Gain 2% to Close Near $223 Amid Earnings Volatility, Credit Upgrade
Earnings James Calloway

AbbVie Shares Gain 2% to Close Near $223 Amid Earnings Volatility, Credit Upgrade

AbbVie stock rose 2% Friday, ending a turbulent week marked by earnings scrutiny and a Moody's credit rating upgrade. Investors remain focused on Skyrizi and Rinvoq growth amid competitive pressures.

ABT JNJ